Equine Herpes Virus 4 (EHV4) Investigation in Aborted Egyptian Mares; Molecular Detection, Isolation, and Phylogeny for Viral Glycoprotein B
Research Article
Equine Herpes Virus 4 (EHV4) Investigation in Aborted Egyptian Mares; Molecular Detection, Isolation, and Phylogeny for Viral Glycoprotein B
Omnia Mohamed Khattab1*, Hala Kamel Abdelmegeed2, Mohamed Mahmoud Mashaly1, Mervat Hamdy1*, Naglaa Hagag1, Ayman Hamed3, Hanan Aly Fahmy3, Essam Ibrahim 4, Momtaz Abdelhady Shahein 2, Elsayyad Mohamed Ahmed2
1Genome Research Unit, Animal Health Research Institute (AHRI), Agriculture Research Center (ARC), Dokki, Giza, 12618 Egypt; 2Virology Department, Animal Health Research Institute (AHRI), Agriculture Research Center (ARC), Dokki, Giza, 12618, Egypt; 3Biotechnology Department, Animal Health Research Institute (AHRI), Agriculture Research Center (ARC), Dokki, Giza, 12618 Egypt; 4Pathology Department, Animal Health Research Institute (AHRI), Agriculture Research Center (ARC), Dokki, Giza, 12618, Egypt.
Abstract | An abortion outbreak was reported in horse studs, Egypt, in 2019. Investigating the role of EHV-4 in this abortion outbreak in mares using various molecular detection techniques were done using the tentative diagnosis by rt-PCR. The presence of 16 liver and spleen samples out of 20 (80%) from aborted fetuses were positive for EHV-4, but all were negative for EHV-1. Virus isolation trial for EHV-4 were done, eleven samples out of 20 (55%) on the CAM of ECE were positive. The virus glycoprotein B (gB) fragment (580pb) was amplified in selected isolates using the nested PCR (n-PCR), sanger sequencing of gB from three isolates with phylogenetic analysis reveals the full identity between the Egyptian isolates from the outbreaks and other EHV-4 strains available in databases proving wide distance with other EHV-8 and EHV-1. The study recommends rt-PCR as a screening test for the tentative diagnosis of EHV-4 in epidemiological studies and n-PCR as a sensitive differential test for the virus detection. The virological studies and molecular assays confirm the involvement of EHV-4 in equine abortion, suggests the possibility that latent virus reactivation in mares could result in abortion due to certain factors, including stress more epidemiological investigation. Whole-genome sequencing is required to address any genetic recombination in EHV-4 associated with abortion cases.
Keywords | EHV-4, Equine, rt-PCR, n-PCR, Sequencing, Phylogenetic analysis, Outbreak
Received | June 21, 2022; Accepted | July 21, 2022; Published | August 16, 2022
*Correspondence | Omnia Mohamed Khattab and Mervat Hamdy, Genome Research Unit, Animal Health Research Institute (AHRI), Agriculture Research Center (ARC), Dokki, Giza, 12618 Egypt; Email: [email protected], [email protected]
Citation | Khattab OM, Abdelmegeed HK, Mashaly MM, Hamdy ME, Hagag N, Hamed A, Fahmy HA, Ibrahim E, Shahein MA, Ahmed EM (2022). Equine herpes virus 4 (EHV4) investigation in aborted Egyptian Mares; molecular detection, isolation, and phylogeny for viral glycoprotein B. Adv. Anim. Vet. Sci. 10(9):1907-1915.
DOI | https://dx.doi.org/10.17582/journal.aavs/2022/10.9.1907.1915
ISSN (Online) | 2307-8316
Copyright: 2022 by the authors. Licensee ResearchersLinks Ltd, England, UK.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Introduction
Equine herpesviruses (EHVs) have a great economic impact on the horses’ industry. They are widely spread globally and are responsible for various diseases in the horse populations (Slater et al., 2006; Telford et al., 1998). Nine herpesviruses have been identified in equids; six belong to the subfamily Alphaherpesvirinae Equine herpesvirus 1 (EHV-1, equine abortion virus), EHV-3 (equine coital exanthema virus), EHV-4 (equine rhino pneumonitis virus), EHV-6 (AHV-1, asinine herpesvirus 1), EHV-8 (AHV3, asinine herpesvirus 3) and EHV-9 (gazelle herpes virus), and three; Equine herpesvirus-2 (EHV-2), Equine herpesvirus-5 (EHV-5) and Equid herpesvirus-7 (EHV-7 or asinine herpesvirus 2) are all members of the Gammaherpesvirinae (Davison et al., 2009).
EHV-1 and EHV-4 belong to the same genus Varicellovirus, regarded as the most important equine herpesviruses. They are genetically and antigenically linked, with cross-reactivity. Antigenic variants, on the other hand, were discovered as early as 1959, and molecular investigations and specific gene sequencing recently revealed genetic differences, and they are two distinct viruses (Harless and Pusterla, 2006; Sabine et al., 1981).
Both EHV-1and EHV-4 viruses have a linear, double-stranded DNA molecule of 150 kbp and 146 kbp in length, respectively; the viral genome structure of the two viruses is composed of a long unique region (U.L.) flanked by a short inverted repeat (TRL/IRL) linked to a unique short area (U.S.) flanked by a substantially inverted repeat (TRS/IRS) (Telford et al., 1992; Telford et al., 1998). EHV-1 genome encodes 80 open reading frames (ORFs), while EHV-4 encodes 79 ORFs. Both EHV-1 and EHV-4 are genetically related viruses with a range of 54.9–96.4% amino acid sequences prediction of their genes (Telford et al., 1998).
EHV1 and EHV-4 are the main viruses responsible for equine viral respiratory diseases with equine influenza virus (EIV) (Pusterla et al., 2011). EHV-1 infection is manifested with respiratory signs, abortion, neonatal foal death, Myelencephalopathy (Slater et al., 2006; Zarski et al., 2021).
EHV-4 causes respiratory diseases in foals two years old or younger and rarely causes abortion (Matsumura et al., 1992; Telford et al., 1998). Still, the EHV-4 becoming latent in the trigeminal ganglion of infected animals is the major outcome and could be reactivated periodically, inducing infection (Borchers et al., 1999; Browning et al., 1988).
A key method for transmitting infection among susceptible animals is asymptomatic carriers’ intermittent recrudescent viral shedding (Patel and Heldens, 2005). Many serological surveys indicated heavy exposure to the virus where more than 80% seroprevalence among horses, donkeys, and mules was detected in different geographical areas (Gilkerson et al., 1999; Mekonnen et al., 2017; Yildirim et al., 2015).
EHV-4 diagnosis of infection and shedding is usually based on molecular detection by polymerase chain reaction (PCR) or quantitative PCR (qPCR) of nasal swabs/washes (Pusterla et al., 2017). Several PCRs using unique primers were intended to identify EHV-1 and EHV-4 in clinical samples, tissues, or cell lines that had been injected with the virus (Dynon et al., 2001; Lawrence et al., 1994; O’Keefe et al., 1994; Wagner et al., 1992). The multiplex PCR and rt-PCR can simultaneously detect and discriminate EHV-1 and EHV-4 from each other (Ataseven et al., 2009; Diallo et al., 2007; Ghoniem et al., 2018).
Serological assays were also developed and validated, such as specific ELISA (Crabb et al., 1995; Hartley et al., 2005) and peptide ELISA (Lang et al., 2013), virus neutralization test (VNT) (OIE, 2018); also virus isolation on primary cell culture and are considered the gold standard assay for laboratory diagnosis and facilitate the comparative and molecular analyses (Lunn et al., 2009; Pavulraj et al., 2021), gene sequencing and whole-genome sequencing are becoming more available and used to identify genetic variations in isolated viruses by phylogenetic analysis (Izume et al., 2017; Telford et al., 1998; Vaz et al., 2016).
In Egyptian economics, horses play a vital role; horses represent about 40% of the estimated 1.5 million equids, according to the Egyptian Ministry of Agriculture, Animal Wealth Development Sector, 2010. EHV-1 circulation has been documented on numerous occasions after it was isolated on two distinct occasions from aborted fetal organs on Chorioallantoic membrane (CAM) of embryonated chicken Eggs (ECE) and cell lines and confirmed by PCR and ELISA (Ahmed et al., 2015; Amer et al., 2011; Warda et al., 2003), few reports are available regarding the EHV-4 and its role in abortion (Afify et al., 2017; Ahmed et al., 2015; Azab et al., 2019).
Because the prevalence of abortion induced via EHV-4 in the field is unknown in Egypt, we performed this study to evaluate the involvement of EHV-4 in the horse abortion outbreak in Egypt, virus isolation and molecular characterization of virus, sequencing and phylogenetic analysis for comparing the sequence of gB isolated from abortion cases and other reported from respiratory one.
Materials and Methods
Ethical approval
The study was carried out following the Animal’s applicable guidelines and regulations in Egypt. No equids were experimentally used or euthanized for this study, and samples were collected post-mortem with prior owners’ consent. All the diagnostic methods and laboratory work were followed the viral isolation, biosafety, and quality standards of AHRI, ARC, Dokki, and Giza, Egypt.
Samples and study area
Tissue samples (n = 20) from aborted fetuses (liver and spleen) and mares were immediately collected aseptically after abortion outbreak notification from horses’ studs in Cairo province, Egypt, during 2019. Samples were transported chilled in proper containers directly to the departments of Virology, biotechnology AHRI, Dokki, and Giza Egypt. It was processed and prepared for investigation of EHV-4 following (OIE) guidelines for EHVs Isolation and identification (OIE, 2018).
Viral DNA extraction
For molecular purposes in this study, Viral genomic DNA was extracted from tissue samples, and isolates showed CPE using the Gene Jet genomic DNA extraction kit (Thermo Fisher Scientific, USA) according to the manufacturer’s instructions.
Molecular detection of EHV-4 by qPCR
Samples from aborted fetuses were initially screened for both EHV-4 in with EHV- 1 using Power CheckTM Equine Herpesvirus type 1 and 4 probe-based qPCR Kit (Kogenbiotech, Seoul, Korea) using total reaction volume 20 μl containing specific primer and probe 4 μl,2x PCR master mix and 5 μl of extracted DNA template or positive control supplied with Kit and nuclease-free water for a negative one, the EHV-1 detected on FAM channel while EHV-4 ON VIC or HEX, all steps were performed according to the instructions included with the kit.
Virus isolation
Virus isolation was done by inoculating specific pathogen-free embryonated chicken Eggs (SPF-ECE) 9-11 days old on CAM (Hassanien et al., 2002). Those that died within 24 hours of being injected were discarded. Death after 24 hours post-inoculation (P.I.) was classified as non-specific.
EHV-4 isolates confirmation by nested PCR
The viral DNA from positive isolates was identified using a nested-PCR (n-PCR) developed by (Borchers and Slater, 1993) and approved by the OIE. The specific primers amplify 580 pb of EHV-4 glycoprotein B (gB) gene target that allows differentiating EHV-4 from EHV-1 were synthesized in (Thermo scientific, USA), the PCR test performed in bio rad thermocycler using a 20 µl as a total reaction volume; 3.5µl of DNA template added to 12.5µl PCR mixture 1x PCR buffer (Amplitaq gold 360® Mix, 2µl from each oligonucleotide primer (20Pmol) in both stages of amplification as recommended by the manufacturer, the primer sequences and amplification conditions are shown in the Table 1. After electrophoresis in % agarose with 10 g/ml ethidium bromide, the PCR products were visualized under ultraviolet light, and the amplification was confirmed.
EHV-4 gB DNA sequencing and phylogenetic analysis
Three viral isolates were selected for genotyping of gB, QIAquick® Gel Extraction Kit (QIAGEN, Germany) was used to purify the PCR products from the second n-PCR stage and then sequenced in both directions with the identical primers and conditions in the AHRI following manufacturer’s instructions for BigDyeTM Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, USA). ChromasPro software was used to remove low-quality portions of the gB gene sequence (ChromasPro 1.7, Technelysium Pty Ltd., Tewantin, Australia). The gB sequences were fetched in the National center for biotechnology information (NCBI) using a Basic local alignment tool for nucleotide (BLASTN), and highly similar sequences for EHV-4 and EHV-8 EHV-1 were selected and downloaded in fatsa format. Multiple sequence alignments (MSA) were performed using the UGEN software and MUSCLE algorism to investigate the evolutionary relationship between the sequenced gene from the current EHV-4 outbreak and other isolates and strains available in the GenBank database (Okonechnikov et al., 2012).
IQ-TREE was used to create the phylogenetic tree (Nguyen et al., 2014), best model finder, and 1000 bootstrap repetitions were used to determine the most accurate model while using the maximum likelihood method. The tree was rescaled to indicate the number of substitutions per site by using branch length as a measure. Display, manipulation, and annotation of the phylogenetic tree were done with the Interactive tree of life (iTOL) (Letunic and Bork, 2021).
Table 1: The EHV-4 oligonucleotide sequences and cycling conditions used in the n-PCR.
n-PCR Stages |
EHV-4 primers |
Sequence |
Cycling conditions (For both steps) |
||
First stage amplification |
BS-4 –P1 |
5'-TCTATTGAGTTTGCTATGCT 3' |
1 cycle |
Initial denaturation |
94ºC /4 min |
BS-4 –P2 |
5'-TCCTGGTTGTTATTGGGTAT 3' |
٤٠ Cycle |
Denaturation |
94ºC/ 30 S |
|
Annealing |
60ºC for 30 S, |
||||
Extension |
72 ºC/90 S. |
||||
Final extension |
72ºCfor10 minutes |
||||
Second stage amplification |
BS-4 –P3 |
5'-TGTTTCCGCCACTCTTGACG 3' |
|||
BS-4 –P4 |
5'-ACTGCCTCTCCCACCTTACC 3' |
Results and Discussion
Outbreaks presentation and molecular detection
The rapid molecular screening with probe-based rt-PCR for the 20 samples from aborted fetuses revealed the presence of EHV-4 in 16 samples (80%), and all samples were negative for EHV-1 as in Figure 1.
Virus isolation
The trial for Isolation of EHV-4 from infected animals on CAM of ECE was successful in eleven samples with high cycle threshold (C.T.) value in rt-PCR, all positive samples the cytopathic effect (CPE) characterized by thickening or diffuse opacity of CAM with the presence of necrotic pock lesion within 5-6 days PI, these lesions were increased with the progressive virus passages till 3rd passage due to the increase of the viral load in isolates. The samples with a low C.T. value in rt-PCR are not propagated in ECE as they contain a low viral load.
Identification of the isolates by n-PCR and sequencing
The genomic DNA of the EHV-4 gB gene was successfully detected by n-PCR, where the target 580 pb fragment was amplified in positive isolates Figure 2, the selected three isolates were sequenced, and the high-quality nucleotide sequences of partial gB gene obtained were deposited in GenBank with accession numbers MW039139, MW039140, MW039141.
Phylogenetic analysis
A phylogenetic tree was constructed the gB sequence of our three EHV-4 isolates with other genome sequences retrieved from the GenBank (Figure 3), MSA and phylogenetic analysis revealed sequence 100% identity between the three EHV-4 field isolates in this study with no differences where they have the same nucleotides and amino acid sequences, using partial and complete genome sequences for EHV-4 gB published in GenBank, our isolates are closely related to the isolates from different geographical location showed 100 % identity with isolates from Japan, Australia, Germany, Turkey, China, Ireland and 99% for 1 isolate from Egypt, all clustered together. The phylogenetic tree of gB clustered the Egyptian three isolates with the other eleven EHV-4 isolates. It proved that all have the same gB except for one nucleotide difference from G to C at position 247 in the isolate of China (MN164456.1) and other single nucleotide polymorphism (SNP) from G to A in isolates from Egypt (KP699582.1) and turkey (JX416464.1) at position 405 of our isolate’s sequences (Figure 4), and this considers a point mutation needed to be investigated. The MSA showed a significant difference between EHV-4 isolates and other EHV-8 and EHV-1 isolates where they reveal similarity with 87 %
Table 2: Source modifier tabulates for gB sequence records retrieved from GenBank for alignment, phylogenetic analysis, and tree construction for EHV-4 isolates from an abortion outbreak in Egypt.
EHV |
Country (location) |
Sample sequence ID |
GenBank Accession number |
Collection date |
Host |
EHV-4 |
Egypt |
EHV4/RV18/Egypt/AHRI/2019 |
MW039139 |
2019 |
Horse |
Egypt |
EHV4/RV22/Egypt/AHRI/2019 |
MW039140 |
2019 |
Horse |
|
Egypt |
EHV4/RL362/Egypt/AHRI/2019 |
MW039141 |
2019 |
Horse |
|
Egypt |
EHV-4|MN592995.1|Cairo-2019. |
MN592995.1 |
2019 |
Horse |
|
Japan |
EHV-4 DNA, strain: 12-I-203 |
LC075588.1 |
2012 |
Horse |
|
Australia |
EHV-4 isolate ER39-67 |
KT324748.1 |
1967 |
Horse |
|
IRLAND |
EHV-4 strain NS80567 |
AF030027.1 |
1998 |
Horse |
|
Turkey |
EHV-4| isolate US4-TR2011 gB gene |
JN982958.1 |
2009 |
Horse |
|
EGYPT |
EHV-4 isolate VRLCU-412-2015 gB gene |
KP699582.1 |
2015 |
Horse |
|
TURKEY |
EHV-4 isolate TR-EHV4-ED-11 gB |
JX416464.1 |
2011 |
Horse |
|
IRLAND |
EHV-4 gB HSEV4 GB. |
M26171.1 |
1989 |
Horse |
|
Germany |
EHV-4 isolate DE17_4 |
MW892438.1 |
2017 |
Horse |
|
CHINA |
EHV-4 envelope glycoprotein B gene |
MN164456.1 |
2018 |
/Horse |
|
Japan |
EHV-4 gB isolate AQHY12LT2104/1/HM |
AB986064.1 |
2012 |
Horse |
|
EHV-8 |
CHINA |
EHV-8 isolate SD2020113 |
MW822570.1 |
2020 |
donkey |
Ireland |
EHV-8 strain EHV-8/IR/2015/40 |
MF431614.1 |
2015 |
donkey |
|
EHV-1 |
GERMANY |
EHV-1 gB gene |
JQ692316.1 |
2010 |
Polar bear |
USA |
EHV-1 strain T-529 10/84 |
KF644580.1 |
2014 |
Onager |
|
Belgium |
EHV-1|strain BE/21P43_BD5/2021 |
MW855960.1 |
2021 |
Horse |
|
JAPAN |
EHV-1 strain: Ab4p_attB_delta_VP22 |
LC193725.1 |
2017 |
Horse |
|
HONG_KONG |
EHV-1 strain Hong Kong/57/1984 |
KU206467.1 |
1984 |
Horse |
|
UK |
EHV-1 strain Suffolk/123/2005 |
KU206480.1 |
2005 |
Horse |
for EHV-8 from Ireland and China and EHV-1 from USA, Germany, UK, Hong Kong, Japan, and Belgium, all sequence details in Table 2 and highlighted nucleotides differences in Figure 5.
At the amino acid level, the sequence translation of the gB sequence from the three Egyptian isolates showed 100 % identity with all selected isolates and strains of EHV-4 except single amino acid in Chinese isolate (MN164456.1), where the A in position 83 is replaced with S, in comparison with EHV-1 and EHV-8 there was a mismatch in 8 amino acid positions that explains the 87 % identity Figure 5.
This study investigates an outbreak of abortion in equines with detection and Isolation of EHV-4 from aborted fetuses during 2019 in special horse studs at Cairo, Egypt. The direct molecular diagnosis using qPCR confirmed the presence of EHV-4 in 16 samples, and all tested fetuses were negative for EHV-1. The virus causes a large economic loss in horses globally and is mostly presented as a respiratory disease with mild to moderate signs in foals and is apparent in mares and stallions (Pusterla et al., 2011). EHV-4 causes inapparent infections in most cases even in foals (Smith et al., 2018).
In the current research the virus was detected in the abortion outbreak that confirms the virus contribution in the abortion incidence in mares which is coincide with previous study as isolates were retrieved from liver and spleen samples of aborted foeti (Gerst et al., 2003; Amer et al., 2011; Afify et al., 2017; Al-Shammari et al., 2016; Mohamed et al., 2017) on other hand detection of the virus from nasal swabs is the main known samples which is in agree with EHV-4 pathogenicity as reported (Amer et al., 2011; Gohneim et al., 2018) and confirm the high prevalence of the virus among horse populations (Amer et al., 2011; Gilkerson et al., 1999) , we detected only EHV-4 as a cause of abortion in this molecular investigation where 16 samples were positive by an rt-PCR, however, mixed infection of both EHV-1/-4 has been previously detected (Taktaz-Hafshejani et al., 2015), preliminary assay for detection EHV-1/-4 is essentially using rapid deferential rt-PCR test for molecular screening of both viruses in equine abortion cases as confirmed the contribution of both virus in the same sample EHV4 1 in addition there is an incidence of reactivation of the latent viruses .Moreover the sensitivity and specificity of viral nucleic acid detection using n-PCR and semi nested PCR agreed in many previous studies which improve the epidemiological investigation and circulation in horse population (Amer et al., 2011; Al-Shammari et al., 2016).
The virus propagation on the CAM of ECE was successful, especially in the samples with high C.T. in rt-PCR where eleven inoculation propagated and displayed a positive cytopathological change as a thickening and diffuse opacity known pock lesion, this result confirms the EHV member isolation as previously done by (Hassanien et al., 2002), and the results proved the higher correlation between the C.T. value in rt -PCR and the possibility of successful Isolation of EHV-4 due to higher viral load in the sample this in agreement with (Pavulraj et al., 2021) where virus isolated from samples with C.T. lower than 25 and the samples with late C.T. not isolated successfully.
The genomic DNA of EHV-4 was detected in horse fetal liver and spleen isolates by successful amplification of a specific 580 pb fragment of virus gB using the n-PCR second cycle, confirming the circulation of EHV-4 and playing a critical role in recurrent abortion outbreaks in Egyptian horses as reported in previous occasions in Egypt (Al-Shammari et al., 2016; Amer et al., 2011; Ghoniem et al., 2018), the finding also prove the superiority of n-nested PCR as a molecular test over the other serological assays. n-PCR could be used as a test of choice in EHV-4 diagnostic due to its accuracy and higher sensitivity up to one viral DNA copy, which overcomes the negativity of serological assays in recently or latently infected horses and reasonable cost with higher sensitivity, especially in low resources countries and where rt-PCR not available, many assays were developed and used by (Borchers and Slater, 1993; Varrasso et al., 2001; Wang et al., 2007).
The phylogenetic analysis with construction of maximum-likelihood tree for the gB sequences from isolates reveals its homology and identity up to 100 % of the three Egyptian isolates with EHV-4 isolates and strains available in GenBank from different localities worldwide as Japan, Australia, Germany, Turkey, China and Ireland, 99% identity with one isolate from Egypt, they were in the same clade with eleven sequences, The Analysis prove that all have the same gB and herpes virus have a low rate of nucleotide substitution and a very stable genomic DNA (Thiry et al., 2005), however we funded one SNP from G to C at position 247 in the isolate from China , another from G to A in isolates from Egypt and turkey at position 405 of our isolate’s sequences , this difference could change on the pathogenicity and lead to alteration in the virus behavior and clinical presentation as occurs in EHV-1 where a point mutation in DNA polymerase was associate with neuropathogenic outbreaks (Nugent et al., 2006), so we recommend further deep investigation by whole genome sequencing for EHV-4 from abortion outbreaks to address any recombination occur .
The EHV-8 was close to EHV-4 in the BLSAT results where similarity revealed less than 87% identity at the nucleotides level and up to 8 amino acids differences in a different position and the same for EHV-4, this distance at genomic level explain the differentiation and large distance between the EHV-1 and -4 subtypes role of gB in cellular tropism, pathogenicity, and epidemiology as studied by (Spiesschaert et al., 2015; Vaz et al., 2016).
This study highlight that EHV-4 virus reactivation and or spread is possible to mares by direct and indirect routes agree with (Vargas-Bermudez et al., 2018), so the stressors play an essential role in the disease outbreaks. Measures are necessary to alleviate stressors in equine studs must be applied as the disease could occur at any time of the year (Matsumura et al., 1992). The result of phylogenetic analysis has shown that EHV4 were homogenous and grouped in one cluster as in the previous study from and out of Egypt, and this study present and confirm the role of EHV-4 as one of the major viral disease causing equine abortion in Egyptian mares, we recommend the strict application of biosecurity measures that will help in minimizing the occurrence of disease outbreaks, quarantine measures with restriction for any new horse entry to the farm, continuous virus monitoring, and regular surveillance and horses immunization. A more epidemiological and molecular investigation is required to address this alteration in the known viral pathogenicity and vaccines efficacy.
Conclusions and Recommendations
In conclusion, EHV-4 is a probable causative agent for equine abortion, the virus infection in aborted fetuses from an outbreak in Egyptian mares was evidenced by rt-PCR, virus isolation, n-PCR, and viral gB sequencing; the disease could result from EHV-4 reactivation in latently infected equine or a true new infection both present a deviation in the previously known form of EHV-4 as a respiratory pathogen, and now it plays an important role in abortion requires more investigation.
Acknowledgements
The authors gratefully acknowledge AHRI, ARC, Dokki, Giza, Egypt.
Funding data
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Novelty Statement
The study confirms the considerable role of EHV-4 as a causative agent for equine abortion, and proves the circulation of EHV-4 during an outbreak of abortion ion 2019 in some Egyptian equine studs as the first report in last years, this study also emphasizes the alteration of the viral pathogenicity as a known respiratory pathogen cause rhinopneumonitis to abortive one, the rt-PCR reveal higher efficacy in viral detection, and we recommend it as a rapid routine diagnostic test. viral gB revealed a higher similarity among EHV-4 isolated from Egypt and globally.
Author’s Contribution
Omnia Khattab, Naglaa M. Hagag, Mervat Hamdy, Mohamed Mashaly: Conceptualization and study design, samples collection, Conducted the experiments and Acquisition of data. data. Elsayyad Ahmed, Mervat E. Hamdy, Hala kamel, Omnia Khatab; Drafted the manuscript, carried out the analysis and data validation. Ayman Hamed, Essam I. Ibrahiem, Hanan Fahmy ,Momtaz A. Shahein and Elsayyad Ahmed; critical revision, data accuracy, supervision and and approval of the final version of the manuscript to be published
All authors read and approved the final manuscript.
Conflict of interest
The authors have declared no conflicts of interest.
References
Afify AF, Ahmed M, Asalem B, El-Sanousi S, Shalaby AAM (2017). First Isolation and identification of EHV-4 during abortion outbreak among Arabian horses in Egypt reflects an alteration in pathogenic potentiality of EHV-4. J. Virol. Sci., 2: 92-101.
Ahmed EM, Mandour MF, Shahein MA, Eldaim MMA, Abdelwahab SA, El-Tarabili MM (2015). Detection of equine herpes virus-1 in Arabian Horses from differentlocalities in Egypt. Anim. Health Res. Inst. J., 3: 31-42.
Al-Shammari, Z., Ahmed BM, Haroun M, Afify AF, Elsanousi AA, Shalaby MA (2016). A first molecular phylogeny of an Egyptian equine herpesvirus-4 strain derived from a fetal Arabian horse. J. Vet. Sci. Med. Diagn., 5: 1. https://doi.org/10.4172/2325-9590.1000186
Amer H, Asmaa KS, Ibrahim MES, Ahmed AES, Mohamed AS (2011). Prevalence of equine herpes viruses 1, 2 and 4 in Arabian horse population in Egypt. Afr. J. Microbiol. Res., 5(27): 4805-4811. https://doi.org/10.5897/AJMR11.421
Ataseven VS, Dagalp SB, Guzel M, Basaran Z, Tan MT, Geraghty B (2009). Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR. Res. Vet. Sci., 86: 339-344. https://doi.org/10.1016/j.rvsc.2008.06.001
Azab W, Bedair S, Abdelgawad A, Eschke K, Farag GK, Abdel-Raheim A, Greenwood AD, Osterrieder N, Ali AAH (2019). Detection of equid herpesviruses among different Arabian horse populations in Egypt. Vet. Med. Sci., 5: 361-371. https://doi.org/10.1002/vms3.176
Borchers K, Slater J (1993). A nested PCR for the detection and differentiation of EHV-1 and EHV-4. J. Virol. Methods, 45: 331-336. https://doi.org/10.1016/0166-0934(93)90117-A
Borchers K, Wolfinger U, Ludwig H (1999). Latency-associated transcripts of equine herpesvirus type 4 in trigeminal ganglia of naturally infected horses. J. Gen. Virol., 80: 2165-2171. https://doi.org/10.1099/0022-1317-80-8-2165
Browning GF, Bulach DM, Ficorilli N, Roy EA, Thorp BH, Studdert MJ (1988). Latency of equine herpesvirus 4 (equine rhinopneumonitis virus). Vet. Rec., 123: 518-519. https://doi.org/10.1136/vr.123.20.518
Crabb BS, MacPherson CM, Reubel GH, Browning GF, Studdert MJ, Drummer HE (1995). A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch. Virol., 140: 245-258. https://doi.org/10.1007/BF01309860
Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E (2009). The order herpesvirales. Arch. Virol., 154: 171-177. https://doi.org/10.1007/s00705-008-0278-4
Diallo IS, Hewitson G, Wright LL, Kelly MA, Rodwell BJ, Corney BG (2007). Multiplex real-time PCR for the detection and differentiation of equid herpesvirus 1 (EHV-1) and equid herpesvirus 4 (EHV-4). Vet. Microbiol., 123: 93-103. https://doi.org/10.1016/j.vetmic.2007.02.004
Dynon K, Varrasso A, Ficorilli N, Holloway S, Reubel G, Li F, Hartley C, Studdert M, Drummer H (2001). Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction. Austral. Vet. J., 79: 695-702. https://doi.org/10.1111/j.1751-0813.2001.tb10674.x
Gerst S, Borchers K, Gower SM, Smith KC (2003). Detection of EHV-1 and EHV-4 in placental sections of naturally occurring EHV-1- and EHV-4-related abortions in the UK: Use of the placenta in diagnosis. Equine Vet. J., 35: 430-433. https://doi.org/10.2746/042516403775600451
Ghoniem SM, El-Deeb AH, Aggour MG, Hussein HA (2018). Development and evaluation of a multiplex reverse-transcription real-time PCR assay for detection of equine respiratory disease viruses. J. Vet. Diagn. Invest., 30: 924-928. https://doi.org/10.1177/1040638718799388
Gilkerson JR, Whalley JM, Drummer HE, Studdert MJ, Love DN (1999). Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm are mares the source of EHV-1 for unweaned foals. Vet. Microbiol., 68: 27-34. https://doi.org/10.1016/S0378-1135(99)00058-9
Harless W, Pusterla N (2006). Equine herpesvirus 1 and 4 respiratory disease in the horse. Clin. Tech. Equine Pract., 5: 197-202. https://doi.org/10.1053/j.ctep.2006.03.014
Hartley CA, Wilks CR, Studdert MJ, Gilkerson JR (2005). Comparison of antibody detection assays for the diagnosis of equine herpesvirus 1 and 4 infections in horses. Am. J. Vet. Res., 66: 921-928. https://doi.org/10.2460/ajvr.2005.66.921
Hassanein MM, El-bagoury F, Kalad MA, El-Kabbany MMA, Daoud MA (2002). Trials for isolation and identification of equine herpesvirus abortion in Egypt. Vet. Med. J. Giza, 50: 977-986.
Izume S, Kirisawa R, Ohya K, Ohnuma A, Kimura T, Omatsu T, Katayama Y, Mizutani T, Fukushi H (2017). The full genome sequences of 8 equine herpesvirus type 4 isolates from horses in Japan. J. Vet. Med. Sci., 79: 206-212. https://doi.org/10.1292/jvms.16-0506
Lang A, de Vries M, Feineis S, Muller E, Osterrieder N, Damiani AM (2013). Development of a peptide ELISA for discrimination between serological responses to equine herpesvirus type 1 and 4. J. Virol. Methods, 193: 667-673. https://doi.org/10.1016/j.jviromet.2013.07.044
Lawrence GL, Gilkerson J, Love DN, Sabine M, Whalley JM (1994). Rapid, single step differentiation of equid herpesvirus 1 and 4 from clinical material using the polymerase chain reaction and virus specific primers. J. Virol. Methods, 47(1-2): 59-72. https://doi.org/10.1016/0166-0934(94)90066-3
Letunic I, Bork P (2021). Interactive tree of life (iTOL) v5: An online tool for phylogenetic tree display and annotation. Nucl. Acids Res., 49: W293-W296. https://doi.org/10.1093/nar/gkab301
Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG (2009). Equine herpesvirus-1 consensus statement. J. Vet. Int. Med., 23: 450-461. https://doi.org/10.1111/j.1939-1676.2009.0304.x
Matsumura T, Sugiura T, Imagawa H, Fukunaga Y, Kamada M (1992). Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. J. Vet. Med. Sci., 54: 207-211. https://doi.org/10.1292/jvms.54.207
Mekonnen A, Eshetu A, Gizaw D (2017). Equine herpesvirus 1 and/or 4 in working equids: Seroprevalence and risk factors in north Shewa Zone, Ethiopia. Ethiop. Vet. J., 21: 28-39. https://doi.org/10.4314/evj.v21i2.3
Mohamed SI, Mohamed AS, Ayman HD, Sayed AS. 2017.Prevalence of equine herpes viruses 1 and 4 in Arabian horses’ population in Egypt J. Virol. Sci., 2: 1-9.
Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ (2014). IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol., 32: 268-274. https://doi.org/10.1093/molbev/msu300
Nugent J, Birch-Machin I, Smith KC, Mumford JA, Swann Z, Newton JR, Bouden RJ, Allen GP, Davis-Poynter N (2006). Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J. Virol., 80: 4047–4060. https://doi.org/10.1128/JVI.80.8.4047-4060.2006
OIE (2018). OIE tersterial maiual, equine rhinopneumonitis (infection with equid herpes virus-1 and -4), chapter 3.6.9, pp. 1320-1332. Avilable online: https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.06.09_EQUINE_RHINO.pdf, accesed in 12-12-2021.
O’Keefe JS, Julian A, Moriarty K, Murray A, Wilks CR (1994). A comparison of the polymerase chain reaction with standard laboratory methods for the detection of EHV-1 and EHV-4 in archival tissue samples. N. Z. Vet. J., 42: 93-96. https://doi.org/10.1080/00480169.1994.35794
Okonechnikov K, Golosova O, Fursov M, Team TU (2012). Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics, 28: 1166-1167. https://doi.org/10.1093/bioinformatics/bts091
Patel JR, Heldens J (2005). Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) epidemiology, disease and immunoprophylaxis: A brief review. Vet. J., 170: 14-23. https://doi.org/10.1016/j.tvjl.2004.04.018
Pavulraj S, Eschke K, Theisen J, Westhoff S, Reimers G, Andreotti S, Osterrieder N, Azab W (2021). Equine herpesvirus type 4 (EHV-4) outbreak in Germany: Virological, serological, and molecular investigations. Pathogens, 10: 810. https://doi.org/10.3390/pathogens10070810
Pusterla N, Kass PH, Mapes S, Johnson C, Barnett DC, Vaala W, Gutierrez C, McDaniel R, Whitehead B, Manning J (2011). Surveillance programme for important equine infectious respiratory pathogens in the USA. Vet. Rec., 169: 12. https://doi.org/10.1136/vr.d2157
Sabine M, Robertson GR, Whalley JM (1981). Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis. Aust. Vet. J., 57: 148-149. https://doi.org/10.1111/j.1751-0813.1981.tb00495.x
Slater JD, Lunn DP, Horohov DW, Antczak DF, Babiuk L, Breathnach C, Chang YW, Davis-Poynter N, Edington N, Ellis S, Foote C, Goehring L, Kohn CW, Kydd J, Matsumura T, Minke J, Morley P, Mumford J, Neubauer T, O’Callaghan D, Osterrieder K, Reed S, Smith K, Townsend H, van der Meulen K, Whalley M, Wilson WD (2006). Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June (2004). Vet. Immunol. Immunopathol., 111: 3-13. https://doi.org/10.1016/j.vetimm.2006.01.004
Smith FL, Watson JL, Spier SJ, Kilcoyne I, Mapes S, Sonder C, Pusterla N (2018). Frequency of shedding of respiratory pathogens in horses recently imported to the United States. J. Vet. Int. Med., 32: 1436-1441. https://doi.org/10.1111/jvim.15145
Spiesschaert B, Osterrieder N, Azab W. 2015. Comparative Analysis of Glycoprotein B (gB) of Equine Herpesvirus Type 1 and Type 4 (EHV-1 and EHV-4) in Cellular Tropism and Cell-to-Cell Transmission. Viruses, 7: 522-542. https://doi.org/10.3390/v7020522
Taktaz-Hafshejani T, Nekoei S, Vazirian B, Doosti A, Khamesipour F, Anyanwu MU (2015). Molecular detection of equine herpesvirus types 1 and 4 infection in healthy horses in Isfahan Central and Shahrekord Southwest Regions, Iran. BioMed. Res. Int., pp. 917854. https://doi.org/10.1155/2015/917854
Telford EA, Watson MS, McBride K, Davison AJ. 1992. The DNA sequence of equine herpesvirus-1. Virology. 189(1): 304-16. doi:10.1016/0042-6822(92)90706-u. PMID: 1318606.
Telford EA, Watson MS, Perry J, Cullinane AA, Davison AJ (1998). The DNA sequence of equine herpesvirus-4. J. Gen. Virol., 79: 1197-1203. https://doi.org/10.1099/0022-1317-79-5-1197
Thiry E, Meurens F, Muylkens B, McVoy M, Gogev S, Thiry J, Vanderplasschen A, Epstein A, Keil G, Schynts F (2005). Recombination in alphaherpesviruses. Rev. Med. Virol., 15: 89-103. https://doi.org/10.1002/rmv.451
Vargas-Bermudez D, Corredor FA, Ramírez-Nieto G, Vera AV, Jaime CJ (2018). Detection of equine herpesvirus 1 and 4 and its association with latency-associated transcripts in naturally infected horses in Colombia. J. Rev. MVZ Córdoba, 23: 6826-6837. https://doi.org/10.21897/rmvz.1371
Varrasso A, Dynon K, Ficorilli N, Hartley CA, Studdert MJ, Drummer HE (2001). Identification of equine herpesviruses 1 and 4 by polymerase chain reaction. Aust. Vet. J., 79: 563-569. https://doi.org/10.1111/j.1751-0813.2001.tb10751.x
Vaz PK, Horsington J, Hartley CA, Browning GF, Ficorilli NP, Studdert MJ, Gilkerson JR, Devlin JM, (2016). Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1. J. Gen. Virol., 97: 747-755. https://doi.org/10.1099/jgv.0.000378
Wagner WN, Bogdan J, Haines D, Townsend HG, Misra V (1992). Detection of equine herpesvirus and differentiation of equine herpesvirus type 1 from type 4 by the polymerase chain reaction. Can. J. Microbiol., 38: 1193-1196. https://doi.org/10.1139/m92-196
Wang L, Raidal SL, Pizzirani A, Wilcox GE (2007). Detection of respiratory herpesviruses in foals and adult horses determined by nested multiplex PCR. Vet. Microbiol., 121: 18-28. https://doi.org/10.1016/j.vetmic.2006.11.009
Warda S, Elkbany M, Soliman E, Kalad M (2003). Studies on some rapid and sensitive techniques for detection of equine herpes virus. Suez Canal Vet. Med. J., 7(2): 463-470.
Yildirim Y, Yilmaz V, Kirmizigul AH (2015). Equine herpes virus type 1 (EHV-1) and 4 (EHV-4) infections in horses and donkeys in northeastern Turkey. Iran. J. Vet. Res., 16: 341-344.
Zarski LM, Giessler KS, Jacob SI, Weber PSD, McCauley AG, Lee Y, Soboll Hussey G (2021). Identification of host factors associated with the development of equine herpesvirus myeloencephalopathy by transcriptomic analysis of peripheral blood mononuclear cells from horses. Viruses, 13: 356. https://doi.org/10.3390/v13030356
To share on other social networks, click on any share button. What are these?